Glenmark Pharmaceuticals Limited (NSE: GLENMARK)

Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 435.04 billion as of December 20, 2024. Its market cap has increased by 98.74% in one year.

• Market Cap: 435.04B
• Enterprise Value: 434.64B
• Revenue: 130.80B
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: 1,541.65

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 435.04B, an increase of 37,752.10%. That is a compound annual growth rate of 28.66%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	435.04B	80.54%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	98.04B	-49.87%